Analysis of PCDD/Fs and PCBs in Human Blood and Characteristics of Contamination Sources

국내 혈액에서의 PCDD/Fs 및 PCBs 분석과 오염원 특성에 관한 연구

  • Yang, Yoon Hee (School of Environmental Science and Engineering, Pohang University of Science & Technology) ;
  • Kim, Byung Hoon (School of Environmental Science and Engineering, Pohang University of Science & Technology) ;
  • Chang, Yoon Seok (School of Environmental Science and Engineering, Pohang University of Science & Technology)
  • 양윤희 (포항공과대학교 환경공학부) ;
  • 김병훈 (포항공과대학교 환경공학부) ;
  • 장윤석 (포항공과대학교 환경공학부)
  • Received : 2000.12.06
  • Published : 2001.04.25

Abstract

Polychlorinated dibenzo-p-dioxins(PCDDs), dibenzofurans(PCDFs), and biphenyls(PCBs) were analyzed by HRGC/HRMS in human blood samples from the Siwha industrial area in Korea. The PCDD/F and PCB concentrations in workers were higher than those in residents. The average TEQ concentrations of PCDD/Fs in workers and residents were 40.3 pg I-TEQs/g lipid and 16.6 pg I-TEQs/g lipid, respectively, and the total PCB concentrations were 174.1 ng/g lipid and 151.0 ng/g lipid, respectively. When applied to principal component analysis, the PCDD/F congener distributions of workers were differentiated from those of residents. But, all of them were similar to the distribution in several Korean foods. Estimated daily intake(EDI) of each person was calculated, and then only 40% to the total people were within the tolerable daily intake range(1-4pg I-TEQ/kg bw/day) suggested by WHO(1997).

고분해능 가스크로마토그래프/고분해능 질량분석기를 이용하여 시화공단 지역 근로자와 일반주민의 혈액에서 다이옥신류를 분석하였다. 평균 다이옥신류의 농도는 근로자가 일반주민보다 높았다. 근로자와 일반주민의 평균 다이옥신 TEQ 농도는 각각 40.3 pg I-TEQ/g lipid, 16.6 pg I-TEQ/g lipid였고, 전체 PCBs 농도는 각각 174.1 ng/g lipid, 151.0 ng/g lipid였다. 주성분분석을 한 결과, 근로자와 일반주민의 다이옥신 이성질체 분포는 구별되었지만, 모두 식품류에서의 분포와 유사하였다. 각 개인의 일일 다이옥신 섭취량을 계산했을 때 40%만이 WHO에서 제시한 1-4 pg I-TEQs/kg bw/day의 허용범주를 만족하였다.

Keywords

References

  1. Occup.Environ.Med. v.52 M.Hansson;T.Grimstad;C.Rappe
  2. Occup.Environ.Med. v.57 S.Kumagai;S.Koda;T.Miyakita;H.Yamaguchi;K.Katagi;N.Yasuda
  3. Chemosphere v.25 no.7-10 O.Papke;M.Ball;A.Lis
  4. Chemosphere v.34 no.5-7 A.Tepper;S.Burt;L.Piacitelli;D.G.Patterson,Jr.
  5. Chemosphere v.38 no.12 T.Iida;H.Hirakawa;T.matsueda;J.Nagayama;T.Nagata
  6. Toxicol.Lett. v.88 U.Ewers;J.Wittsiepe;P.Schrey;F.Selenka
  7. J.Toxicol.Environ. v.47 D.Flesch-Janys;H.Becher;P.Gurn;D.Jung;J.Konietzko;A.Manz;O.Papke
  8. Regul.Toxicol.Pharmacol. v.30 F.Pollitt
  9. 분석과학 v.13 no.4 양윤희;장윤석;김병훈;양지연;신동천
  10. Technometrics v.20 S.Wold
  11. Chemosphere v.38 no.9 J.E.Oh;K.T.Lee;J.W.Lee;Y.S.Chang
  12. Chemosphere v.38 no.11 K.J.Shin;Y.S.Chang
  13. 한국환경분석학회지 v.2 no.3 김종국;김경심;이병호
  14. Toxicol.Environ.Chem. v.26 F.W.Kutz;D.G.Barnes;E.W.Bretthauer;D.P.Bottimore;H.Greim
  15. Environ.Health Perspect. v.106 no.12 M.V.den Berg;L.Birnbaum;A.T.C.Bosveld;B.Brunstrom;P.Cook;M.Feeley;J.P.Giesy;A.Hanberg;R.Hasegawa;S.W.Kennedy;T.Kubiak;J.C.Larsen;F.X.R.van Leeuwen;A.K.D.Liem;C.Nolt;R.E.Peterson;L.Poellinger;S.Safe;D.Schrenk;D.Tillitt;M.Tysklind;M.Younes;F.Wærn;T.Zacharewski
  16. Toxicol.Pharmacol. v.18 no.2 R.J.Fensterheim
  17. Organohalogen Comp. v.30 A.K.D.Liem;U.G.Ahlborg;H.Beck;F.Haschke;M.Nygren;M.Younes;E.Yrjanheikki
  18. Aviat.Space Environ.Med. v.54 J.J.Knapik;R.L.Burse;J.A.Vogel
  19. Assessment of the health risk of dioxins: re-evaluation of the Tolerable Daily Intake(TDI), Executive Summary WHO European Centre for Environment and Health International Programme on Chemical Safety